Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit
MALVERN, Pa., Nov. 07, 2023 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today...
Source: marketscreener.com